Innovative medicines for serious diseases
Bristol Myers Squibb (2seventybio.com) scores 74 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 41st percentile of 19340 Healthcare brands.
Bristol Myers Squibb is an American global biopharmaceutical company headquartered in New York City, founded in 1989. The company discovers, develops, and delivers innovative medicines for patients with serious diseases, focusing on areas such as oncology, immunology, and cardiovascular disease. It serves patients, healthcare providers, researchers, and the broader medical community, combining scientific expertise with a patient-centered approach to advance therapeutic solutions worldwide.
| Brand Name | Bristol Myers Squibb |
|---|---|
| Domain | 2seventybio.com |
| Industry | Healthcare |
| Founded | 1989 |
| Headquarters | New York City |
| CEO | Giovanni Caforio |
| Main Competitors | Pfizer (89/100), Merck (81/100), Johnson & Johnson (87/100), AbbVie (83/100), Novartis (75/100), Roche (81/100), Eli Lilly (78/100), GlaxoSmithKline (83/100), Sanofi (90/100), AstraZeneca (82/100) |
Moz Domain Authority 36/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Bristol Myers Squibb has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases." (Meta description: 21 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 4 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Facebook, Instagram, X (Twitter), YouTube; no detected presence on GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Bristol Myers Squibb's main competitors in Healthcare: Pfizer (89/100), Merck (81/100), Johnson & Johnson (87/100), AbbVie (83/100), Novartis (75/100).
Sources: Brand Analyzer scan
Bristol Myers Squibb is an American global biopharmaceutical company headquartered in New York City. Founded in 1989, it focuses on discovering, developing, and delivering innovative medicines for patients with serious diseases. The company operates across multiple therapeutic areas, including oncology, immunology, and cardiovascular disease, and is led by CEO Giovanni Caforio.
Sources: Bristol Myers Squibb official site
Bristol Myers Squibb has limited AI-search visibility, scoring 49/100 on Brand Analyzer's AI visibility composite (visibility 65, trust 32, recommendation 42). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Bristol Myers Squibb official site
Bristol Myers Squibb was founded in 1989. Bristol Myers Squibb operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Bristol Myers Squibb is headquartered in New York City. Bristol Myers Squibb operates in the Healthcare category.
Sources: Wikidata
Bristol Myers Squibb scores 42/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Bristol Myers Squibb official site
Bristol Myers Squibb can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Bristol Myers Squibb official site
Bristol Myers Squibb's offerings are used by patients with serious diseases, as well as healthcare providers, researchers, and the broader medical community seeking advanced therapeutic solutions.
Sources: Bristol Myers Squibb official site
Bristol Myers Squibb is known for its role as a global biopharmaceutical leader developing innovative medicines, particularly in oncology, immunology, and cardiovascular disease, combining scientific research with a patient-centered approach to create transformative therapies.
Sources: Bristol Myers Squibb official site
Bristol Myers Squibb scores 49/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Bristol Myers Squibb has a limited AI-visibility profile at 49/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (65/100) and its weakest is trust (32/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: a low Moz Domain Authority of 36/100 and no llms.txt to steer AI to its best pages.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Bristol Myers Squibb: 14th Street Y (74/100), 1199SEIU (74/100), 7wire Ventures (74/100), American Academy of Cosmetic Dentistry (AACD) (74/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.